Cargando…
New treatment options for metastatic renal cell carcinoma with prior anti-angiogenesis therapy
Angiogenesis is a critical process in the progression of advanced renal cell carcinoma. Agents targeting angiogenesis have played a primary role in the treatment of metastatic renal cell carcinoma. However, resistance to anti-angiogenesis therapy almost always occurs, and major progress has been mad...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288948/ https://www.ncbi.nlm.nih.gov/pubmed/28153029 http://dx.doi.org/10.1186/s13045-016-0374-y |